- Home
- ATNM vs APT Comparison
ATNM vs APT Comparison
Compare ATNM & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- APT
- Stock Information
- Founded
- ATNM 2000
- APT 1983
- Country
- ATNM United States
- APT Canada
- Employees
- ATNM N/A
- APT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- ATNM Health Care
- APT
- Exchange
- ATNM Nasdaq
- APT Nasdaq
- Market Cap
- ATNM 50.2M
- APT 50.4M
- IPO Year
- ATNM N/A
- APT 1995
- Fundamental
- Price
- ATNM $1.58
- APT $4.79
- Analyst Decision
- ATNM Strong Buy
- APT
- Analyst Count
- ATNM 2
- APT 0
- Target Price
- ATNM $4.50
- APT N/A
- AVG Volume (30 Days)
- ATNM 116.8K
- APT 22.1K
- Earning Date
- ATNM 11-13-2025
- APT 11-05-2025
- Dividend Yield
- ATNM N/A
- APT N/A
- EPS Growth
- ATNM N/A
- APT N/A
- EPS
- ATNM N/A
- APT 0.33
- Revenue
- ATNM N/A
- APT $58,562,000.00
- Revenue This Year
- ATNM N/A
- APT N/A
- Revenue Next Year
- ATNM N/A
- APT N/A
- P/E Ratio
- ATNM N/A
- APT $14.56
- Revenue Growth
- ATNM N/A
- APT N/A
- 52 Week Low
- ATNM $1.03
- APT $4.06
- 52 Week High
- ATNM $2.41
- APT $6.20
- Technical
- Relative Strength Index (RSI)
- ATNM 42.17
- APT 49.72
- Support Level
- ATNM $1.56
- APT $4.75
- Resistance Level
- ATNM $1.64
- APT $4.84
- Average True Range (ATR)
- ATNM 0.06
- APT 0.12
- MACD
- ATNM -0.01
- APT -0.00
- Stochastic Oscillator
- ATNM 6.67
- APT 42.86
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.